Researcher Next
Create account
← Back to directory

Andreas Rimner

Researcher Next ID · RN-038690

Researcher · Medicine

Memorial Sloan Kettering Cancer Center

New York, Denmark

Sign in to saveSign in to claim
Accepting doctoral researchersFunding unknown
Works count
585
Citation count
13,288
H-index
59
i10-index
200

Research interests

Medicine
Physics and Astronomy
Lung Cancer Diagnosis and Treatment
Advanced Radiotherapy Techniques
Lung Cancer Treatments and Mutations
Radiomics and Machine Learning in Medical Imaging
Occupational and environmental lung diseases

Publications

  • Evolution of systemic therapy for stages I–III non-metastatic non-small-cell lung cancer

    Nature Reviews Clinical Oncology · 2021 · https://doi.org/10.1038/s41571-021-00501-4

  • Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

    Journal of Thoracic Oncology · 2021 · https://doi.org/10.1016/j.jtho.2020.12.015

  • Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

    Radiotherapy and Oncology · 2020 · https://doi.org/10.1016/j.radonc.2020.04.001

  • Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

    Radiation Oncology · 2020 · https://doi.org/10.1186/s13014-020-01654-9

  • Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline

    Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2017.76.6394

  • Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline

    Practical Radiation Oncology · 2017 · https://doi.org/10.1016/j.prro.2017.04.014

  • Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

    PubMed · 2001

Current projects

    No projects listed.